Piper Sandler Cuts AirSculpt Technologies (NASDAQ:AIRS) Price Target to $6.00

AirSculpt Technologies (NASDAQ:AIRS) had its price objective reduced by Piper Sandler from $7.00 to $6.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have a neutral rating on the stock.

Separately, BTIG Research started coverage on AirSculpt Technologies in a report on Thursday, October 17th. They issued a “neutral” rating on the stock. Five investment analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $5.50.

AirSculpt Technologies Stock Performance

Shares of AIRS stock opened at $6.03 on Monday. The stock has a market capitalization of $349.03 million, a PE ratio of -43.07 and a beta of 1.71. AirSculpt Technologies has a 52-week low of $2.92 and a 52-week high of $9.20. The stock’s 50-day moving average price is $6.39 and its 200 day moving average price is $5.21. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.80.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings results on Friday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05). The company had revenue of $42.55 million during the quarter, compared to analyst estimates of $42.49 million. AirSculpt Technologies had a negative net margin of 4.13% and a positive return on equity of 2.22%. During the same quarter last year, the firm earned ($0.01) EPS. As a group, equities research analysts forecast that AirSculpt Technologies will post 0.08 EPS for the current year.

Insider Transactions at AirSculpt Technologies

In other news, CEO Dennis Dean sold 24,510 shares of the business’s stock in a transaction that occurred on Friday, November 15th. The stock was sold at an average price of $6.54, for a total transaction of $160,295.40. Following the sale, the chief executive officer now owns 582,052 shares of the company’s stock, valued at $3,806,620.08. The trade was a 4.04 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 78.77% of the company’s stock.

Institutional Investors Weigh In On AirSculpt Technologies

Institutional investors and hedge funds have recently bought and sold shares of the stock. Barclays PLC lifted its stake in AirSculpt Technologies by 227.0% in the 3rd quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after buying an additional 13,259 shares in the last quarter. Geode Capital Management LLC lifted its stake in AirSculpt Technologies by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after buying an additional 21,339 shares in the last quarter. Finally, SW Investment Management LLC lifted its stake in AirSculpt Technologies by 5.0% in the 2nd quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock valued at $18,000,000 after buying an additional 213,677 shares in the last quarter. Hedge funds and other institutional investors own 91.54% of the company’s stock.

About AirSculpt Technologies

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.